Abstract:Abstract Background Breast cancer is the most prevalent and among the most deadly cancers in females. Patients with breast cancer have highly variable survival lengths, indicating a need to identify prognostic biomarkers for personalized diagnosis and treatment. With the development of new technologies such as next-generation sequencing, multi-omics information are becoming available for a more thorough evaluation of a patient’s condition. In this study, we aim to improve breast cancer overall survival prediction by integrating multi-omics data (e.g., gene expression, DNA methylation, miRNA expression, and copy number variations (CNVs)). Methods Motivated by multi-view learning, we propose a novel strategy to integrate multi-omics data for breast cancer survival prediction by applying complementary and consensus principles. The complementary principle assumes each -omics data contains modality-unique information. To preserve such information, we develop a concatenation autoencoder (ConcatAE) that concatenates the hidden features learned from each modality for integration. The consensus principle assumes that the disagreements among modalities upper bound the model errors. To get rid of the noises or discrepancies among modalities, we develop a cross-modality autoencoder (CrossAE) to maximize the agreement among modalities to achieve a modality-invariant representation. We first validate the effectiveness of our proposed models on the MNIST simulated data. We then apply these models to the TCCA breast cancer multi-omics data for overall survival prediction. Results For breast cancer overall survival prediction, the integration of DNA methylation and miRNA expression achieves the best overall performance of 0.641 ± 0.031 with ConcatAE, and 0.63 ± 0.081 with CrossAE. Both strategies outperform baseline single-modality models using only DNA methylation (0.583 ± 0.058) or miRNA expression (0.616 ± 0.057). Conclusions In conclusion, we achieve improved overall survival prediction performance by utilizing either the complementary or consensus information among multi-omics data. The proposed ConcatAE and CrossAE models can inspire future deep representation-based multi-omics integration techniques. We believe these novel multi-omics integration models can benefit the personalized diagnosis and treatment of breast cancer patients.

Multi-omics Fusion Based on Attention Mechanism for Survival and Drug Response Prediction in Digestive System Tumors

Multi-Omics Analysis for Improved Diagnosis, Prognosis, and Drug Response Prediction in Digestive System Tumors

Enhancing Non-Small Cell Lung Cancer Survival Prediction through Multi-Omics Integration Using Graph Attention Network

Multi‐omics Graph Convolutional Networks for Digestive System Tumour Classification and Early‐late Stage Diagnosis

HMM-GDAN: Hybrid Multi-View and Multi-Scale Graph Duplex-Attention Networks for Drug Response Prediction in Cancer.

Multimodal Survival Ensemble Network: Integrating Genomic and Histopathological Insights for Enhanced Cancer Prognosis.

Deep learning based feature-level integration of multi-omics data for breast cancer patients survival analysis

FGCNSurv: dually fused graph convolutional network for multi-omics survival prediction

A Multimodal Affinity Fusion Network for Predicting the Survival of Breast Cancer Patients

A Multi-Omics Integration Framework Using Graph Attention Networks for Cancer Subtype Prediction

Dual-stream multi-dependency graph neural network enables precise cancer survival analysis

TTMFN: Two-stream Transformer-based Multimodal Fusion Network for Survival Prediction

Prediction of Cancer Drug Effectiveness Based on Multi-Fusion Deep Learning Model

Deep learning assisted multi-omics integration for survival and drug-response prediction in breast cancer

Pathology-genomic fusion via biologically informed cross-modality graph learning for survival analysis

Survival Prediction for Non-Small Cell Lung Cancer Based on Multimodal Fusion and Deep Learning

MGCT: Mutual-Guided Cross-Modality Transformer for Survival Outcome Prediction using Integrative Histopathology-Genomic Features

Multi-omics Cancer Prognosis Analysis Based on Graph Convolution Network.

Multi-omics fusion analysis models with machine learning predict survival of HER2-negative metastatic breast cancer: a multicenter prospective observational study

MSFN: a multi-omics stacked fusion network for breast cancer survival prediction

Pancancer survival prediction using a deep learning architecture with multimodal representation and integration